No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Time-of-infusion with immunotherapy may impact survival outcomes for patients with advanced melanoma

byTeddy Guo

February 16, 2022

in StudyGraphics

Reading Time: 1 min read

Psychological experiment suggests genetic testing may influence neonatologists’ clinical decision-making

RelatedReports

Chronic Disease

Enfortumab vedotin plus pembrolizumab is more effective than platinum-based chemotherapy in metastatic urothelial carcinoma

July 9, 2026

Quick Take: Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening

Oncology

Atezolizumab may improve disease-free survival in mismatch repair deficiency locally advanced colon cancer

April 8, 2026

Eczema more prevalent among older adults than previously thought

Cardiology

Atopic dermatitis activity is not associated with cardiovascular risk

April 2, 2026

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

All Specialties

Oral remibrutinib hits Phase 3 primary endpoint for inducible hives

March 5, 2026

USPSTF finds insufficient evidence for screening for iron deficiency anemia during pregnancy

Pregnant patients with epilepsy may benefit from increased doses of anticonvulsant medications

Adalimumab use results in high clinical response rate in hidradenitis suppurativa

Hyperimmune immunoglobulin does not improve outcomes in patients hospitalized with COVID-19

#VisualAbstract: Mobile stroke units associated with better outcomes for acute ischemic stroke management

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports